This page is part of our 2019 average annual return archive: it shows the ALNY stock yearly return for calendar year 2019. This metric helps investors evaluate and compare performance among different stocks, over time.
Average annual return should be reviewed alongside overall market trends, and company fundamentals like earnings and revenue. As the saying goes on Wall St., past performance from 2019 does not guarantee future similar returns.
| ALNY Stock Yearly Return 2019 Table | ||||||||||||||||||||||||||||||
ALNY average annual return is presented with the assumption of reinvestments of any dividends on ex-date. |
| Average Annual Return Benchmarks |
|
Compare ALNY average annual return versus benchmarks: S&P Average Annual Return Dow Average Annual Return Nasdaq 100 Average Annual Return Russell 2000 Average Annual Return Gold Average Annual Return 10 Year Treasury Average Annual Return |
| ALNY Share Performance |
| ALNY Stock Yearly Return 2019 Chart | |||
Also see: • ALNY stock yearly return 2020 • ALNY YTD return • ALNY average annual return 10 years | |||
| About Alnylam Pharmaceuticals Inc |
| Alnylam Pharmaceuticals is a commercial-stage biopharmaceutical company developing therapeutics based on RNA interference (RNAi). RNAi is a biological pathway within cells for sequence-specific silencing and regulation of gene expression. Co. has two RNAi-based medicines, ONPATTRO® (patisiran) and GIVLAARI® (givosiran). ONPATTRO is approved by the United States Food and Drug Administration (FDA) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults and has also been approved in the European Union, Japan, Canada and Switzerland. GIVLAARI is approved by FDA for the treatment of adults with acute hepatic porphyria. The ALNY stock yearly return is shown above.
The yearly return on the ALNY stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon. One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the ALNY annual return calculation with any dividends reinvested as applicable (on ex-dates). |
| ALNY Current Stock Quote |
Get Free SEC filing alerts for ALNY:
ALNY SEC Filing Email Alerts Service 
|
| Video: Don't Forget Dividends in Annual Return! | |
|
| Yearly Return Peers |
| Alnylam Pharmaceuticals (ALNY) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:
ALOG Average Annual Return |
Video: Don't Forget Dividends in Average Annual Return!